<p>The present invention includes isolated anti-Langerin vaccines, methods for making and using an isolated anti-Langerin antibody or binding fragment thereof and one or more antigenic peptides at the carboxy- terminus of the isolated anti-Langerin antibody, wherein when two or more antigenic peptides are present, the peptides are separated by the one or more linker peptides that comprise at least one glycosylation site. The present invention also includes isolated vectors for the expression of the anti-Langerin antigen delivery vectors and their manufactures and use.</p>
申请公布号
WO2011032161(A3)
申请公布日期
2011.08.25
申请号
WO2010US48800
申请日期
2010.09.14
申请人
BAYLOR RESEARCH INSTITUTE;BANCHEREAU, JACQUES, F.;ZURAWSKI, SANDRA;ZURAWSKI, GERARD;KLECHEVSKY, EYNAV;OH, SANGKON